TY - JOUR
T1 - Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic
T2 - An ACC/SCAI Position Statement
AU - American College of Cardiology and the Society for Cardiovascular Angiography and Interventions
AU - Shah, Pinak B.
AU - Welt, Frederick G.P.
AU - Mahmud, Ehtisham
AU - Phillips, Alistair
AU - Kleiman, Neal S.
AU - Young, Michael N.
AU - Sherwood, Matthew
AU - Batchelor, Wayne
AU - Wang, Dee Dee
AU - Davidson, Laura
AU - Wyman, Janet
AU - Kadavath, Sabeeda
AU - Szerlip, Molly
AU - Hermiller, James
AU - Fullerton, David
AU - Anwaruddin, Saif
N1 - Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2020/6/22
Y1 - 2020/6/22
N2 - The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.
AB - The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.
KW - COVID-19
KW - MitraClip
KW - TAVR
KW - structural heart disease
KW - Heart Diseases/surgery
KW - Humans
KW - Coronavirus Infections/epidemiology
KW - Pandemics/prevention & control
KW - Patient Selection
KW - Cardiovascular Surgical Procedures
KW - Pneumonia, Viral/epidemiology
KW - Ambulatory Surgical Procedures
KW - Betacoronavirus
KW - Referral and Consultation
KW - Triage
UR - http://www.scopus.com/inward/record.url?scp=85083246774&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083246774&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2020.04.001
DO - 10.1016/j.jcin.2020.04.001
M3 - Article
C2 - 32250751
AN - SCOPUS:85083246774
VL - 13
SP - 1484
EP - 1488
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
SN - 1936-8798
IS - 12
ER -